sever
acut
respiratori
syndrom
sar
coronaviru
cov
contain
spike
protein
bind
receptor
molecul
angiotensinconvert
enzym
induc
membran
fusion
serv
neutral
epitop
studi
function
protein
describ
gener
sarscov
proteinbear
vesicular
stomat
viru
vsv
pseudotyp
use
gfp
system
g
gene
replac
green
fluoresc
protein
gfp
gene
partial
delet
cytoplasm
domain
sarscov
protein
allow
effici
incorpor
vsv
particl
enabl
gener
high
titer
pseudotyp
viru
neutral
assay
antisarscov
antibodi
reveal
pseudotyp
infect
mediat
sarscov
protein
seap
system
secret
alkalin
phosphatas
instead
gfp
also
gener
vsv
pseudotyp
sarscov
protein
system
enabl
highthroughput
analysi
sarscov
proteinmedi
cell
entri
measur
alkalin
phosphatas
activ
thu
vsv
pseudotyp
sarscov
protein
use
develop
rapid
detect
system
neutral
antibodi
specif
sarscov
infect
well
studi
smediat
cell
entri
sarscov
entri
sar
coronaviru
sarscov
target
cell
mediat
bind
viral
spike
protein
receptor
molecul
angiotensinconvertingenzym
studi
sar
use
infecti
sarscov
requir
care
highli
pathogen
natur
viru
altern
methodolog
need
recent
pseudotyp
retroviru
particl
bear
sarscov
protein
gener
sever
laboratori
pseudotyp
virus
shown
cell
tropism
ident
authent
sarscov
infect
depend
indic
infect
mediat
sole
sarscov
protein
pseudotyp
virus
prove
safe
viral
entri
model
inabl
produc
infecti
progeni
viru
quantit
assay
pseudoviru
infect
could
facilit
research
sarscov
entri
cell
tropism
neutral
antibodi
anoth
pseudotyp
system
vesicular
stomat
viru
vsv
particl
previous
report
produc
pseudotyp
envelop
glycoprotein
sever
rna
virus
ie
measl
viru
hantaviru
ebola
viru
hepat
c
viru
system
gfp
system
may
use
research
envelop
glycoprotein
owe
abil
grow
high
titer
varieti
cell
line
pseudotyp
viru
titer
obtain
gfp
system
infecti
unit
iu
ml
gener
higher
pseudotyp
retroviru
system
furthermor
infect
pseudotyp
vsv
target
cell
detect
gfpposit
cell
within
h
postinfect
hpi
power
gfpexpress
gfp
system
contrast
time
requir
pseudotyp
retroviru
system
detect
infect
hpi
similar
sarscov
replic
level
produc
plaqu
cytopath
effect
infect
cell
thu
pseudotyp
sarscov
protein
use
gfp
system
may
greater
advantag
retroviru
pseudotyp
studi
function
sarscov
protein
well
develop
rapid
system
detect
neutral
antibodi
specif
sarscov
describ
protocol
introduc
sarscov
protein
vsv
particl
use
gfp
system
infect
vsv
pseudotyp
bear
sarscov
protein
easili
detect
target
cell
express
gfp
protein
follow
method
origin
design
produc
measur
infect
effici
addit
signific
advantag
safe
rapid
analys
infect
seap
system
g
gene
replac
secret
alkalin
phosphatas
seap
gene
may
superior
highthroughput
quantit
analysi
smediat
cell
entri
protocol
analyz
pseudotyp
use
seap
system
also
describ
briefli
schemat
descript
product
vsv
pseudotyp
shown
fig
viral
compon
except
g
protein
suppli
virus
viru
assembl
bud
pseudotyp
translat
viral
protein
assembl
viral
particl
bud
plasma
membran
sinc
protein
provid
express
plasmid
express
cell
surfac
viru
incorpor
viru
particl
infect
harbor
gfp
genom
determin
number
gfpposit
cell
mix
serial
dilut
fc
inocul
mixtur
vero
cell
seed
cultur
plate
incub
cell
co
incub
h
longer
incub
overnight
h
may
benefici
clearer
fluoresc
intens
gfpposit
cell
detect
gfpposit
cell
use
fluoresc
microscopi
fig
determin
iu
pseudotyp
iu
defin
viru
titer
endpoint
determin
limit
dilut
incub
cell
co
incub
overnight
determin
seap
activ
perform
specif
seap
assay
kit
sever
kit
differ
manufactur
avail
sinc
manufactur
protocol
detail
vari
gener
descript
follow
base
toyobo
kit
use
techniqu
use
plate
twenti
l
supernat
cell
cultur
ad
well
equal
volum
endogen
alkalin
phosphatas
inhibitor
incub
mixtur
c
min
next
add
l
chemiluminesc
substrat
mixtur
incub
min
c
allow
chemiluminesc
reaction
use
luminesc
micropl
reader
detect
chemiluminesc
signal
gener
high
viru
titer
vsv
pseudotyp
prepar
plasmid
encod
ctermin
truncat
version
protein
shown
truncat
ctermin
amino
acid
lead
effici
incorpor
protein
vsv
particl
vsv
pseudotyp
show
effici
infect
target
cell
gfpg
vsvg
proteinbear
vsv
pseudotyp
vsvg
gene
replac
gfp
gene
seapg
gfpg
except
seap
gene
instead
gfp
gene
pseudotyp
vsvg
protein
use
seed
virus
gener
protein
bear
vsv
pseudotyp
sinc
gfp
seap
system
develop
prof
whitt
univers
tennesse
health
scienc
center
tn
ask
share
use
system
start
experi
seap
gene
obtain
modif
human
placent
alkalin
phosphatas
gene
cell
line
deriv
placenta
express
alkalin
phosphatas
similar
seap
use
target
cell
analysi
infect
suggest
use
vero
cell
show
low
level
alkalin
phosphatas
activ
cultur
supernat
medium
contain
may
strong
seap
activ
sinc
deriv
cultur
medium
cell
inocul
seapg
see
step
section
order
remov
carryov
seap
activ
deriv
seapg
vero
cell
wash
pb
least
three
time
